-
1
-
-
0031448068
-
Anti-inflammatory theraphy for Alzheimer's disease: A status report
-
Aisen PS, Davis KL. Anti-inflammatory theraphy for Alzheimer's disease: a status report. Int J Geriatr Psychopharmacol 1997; 1:2-5.
-
(1997)
Int J Geriatr Psychopharmacol
, vol.1
, pp. 2-5
-
-
Aisen, P.S.1
Davis, K.L.2
-
2
-
-
0030250376
-
Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: A current appraisal
-
Breitner JC. Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol Aging 1996; 17(5):789-794.
-
(1996)
Neurobiol Aging
, vol.17
, Issue.5
, pp. 789-794
-
-
Breitner, J.C.1
-
3
-
-
0028103819
-
Inflammatory mechanisms in Alzheimer's disease. Implication for therapy
-
Aisenb PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease. Implication for therapy. Am J Psych 1994; 151:1105-1111.
-
(1994)
Am J Psych
, vol.151
, pp. 1105-1111
-
-
Aisenb, P.S.1
Davis, K.L.2
-
4
-
-
0025801468
-
Is amyloidgenesis during Alzheimer's disease due to an IL-1/IL-6 mediated "acute phase response" on the brain?
-
Nanderabelle P, Freis W. Is amyloidgenesis during Alzheimer's disease due to an IL-1/IL-6 mediated "acute phase response" on the brain? Immunol Today 1991; 12:217-219.
-
(1991)
Immunol Today
, vol.12
, pp. 217-219
-
-
Nanderabelle, P.1
Freis, W.2
-
5
-
-
0030250826
-
Inflammatory mechanisms in neurodegeration and Alzheimer's disease: The role of the complement system
-
Pasinetti GM. Inflammatory mechanisms in neurodegeration and Alzheimer's disease: the role of the complement system. Microbiol Aging 1996; 17:707-716.
-
(1996)
Microbiol Aging
, vol.17
, pp. 707-716
-
-
Pasinetti, G.M.1
-
6
-
-
0345094772
-
Expression of immune system-associated antigen by cells of the human nervous system: Relationship to the pathology of Alzheimer's disease
-
Roger J, Luber-Narod J, Styror SD, Civin WN. Expression of immune system-associated antigen by cells of the human nervous system: relationship to the pathology of Alzheimer's disease. Microbiol Aging 1988; 9:330-349.
-
(1988)
Microbiol Aging
, vol.9
, pp. 330-349
-
-
Roger, J.1
Luber-Narod, J.2
Styror, S.D.3
Civin, W.N.4
-
7
-
-
0027433102
-
Neurologic disease induced in transgenic mice by overexpression of interleukin 6
-
Campbell LL, Abraham CA, Masliah E. Neurologic disease induced in transgenic mice by overexpression of interleukin 6. Proc Natl Acad Sci USA 1993; 90:100061-100065.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 100061-100065
-
-
Campbell, L.L.1
Abraham, C.A.2
Masliah, E.3
-
8
-
-
0030014166
-
IL-1 and anti-inflammatory drugs modulate Aβ cytotoxicity in DC12 cells
-
Ferguson MO, Aisen PJ. IL-1 and anti-inflammatory drugs modulate Aβ cytotoxicity in DC12 cells. Brain Res 1996; 723:231-234.
-
(1996)
Brain Res
, vol.723
, pp. 231-234
-
-
Ferguson, M.O.1
Aisen, P.J.2
-
9
-
-
0025635923
-
Acase control study of Alzheimer's disease
-
Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB. Acase control study of Alzheimer's disease. Ann Neurol 1990; 28:766-774.
-
(1990)
Ann Neurol
, vol.28
, pp. 766-774
-
-
Graves, A.B.1
White, E.2
Koepsell, T.D.3
Reifler, B.V.4
Van Belle, G.5
Larson, E.B.6
-
10
-
-
0025016324
-
A case controlled study of Alzheimer's disease in Australia
-
Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF. A case controlled study of Alzheimer's disease in Australia. Neurology 1990; 40:1698-1707.
-
(1990)
Neurology
, vol.40
, pp. 1698-1707
-
-
Broe, G.A.1
Henderson, A.S.2
Creasey, H.3
McCusker, E.4
Korten, A.E.5
Jorm, A.F.6
-
11
-
-
0026689830
-
Environmental risk factors for Alzheimer's disease: Their relationship to age of onset and to familial or sporadic types
-
Henderson AS, Jorm AF, Korten AE, Creaey H, McCusker E, Broe GA. Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic types. Psychol Med 1992; 22:429-436.
-
(1992)
Psychol Med
, vol.22
, pp. 429-436
-
-
Henderson, A.S.1
Jorm, A.F.2
Korten, A.E.3
Creaey, H.4
McCusker, E.5
Broe, G.A.6
-
12
-
-
0028289083
-
Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin controlled study
-
Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin controlled study. Neurology 1994; 44:227-232.
-
(1994)
Neurology
, vol.44
, pp. 227-232
-
-
Breitner, J.C.1
Gau, B.A.2
Welsh, K.A.3
Plassman, B.L.4
McDonald, W.M.5
Helms, M.J.6
-
13
-
-
0028080315
-
Risk factors for Alzheimer's disease in Canada
-
The Canadian Study of Health and Aging. Risk factors for Alzheimer's disease in Canada. Neurology 1994; 44:2073-2080.
-
(1994)
Neurology
, vol.44
, pp. 2073-2080
-
-
-
14
-
-
0029811901
-
Arthritis and anti-inflammatory agents are possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
-
Mcgeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents are possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 1996; 47:425-432.
-
(1996)
Neurology
, vol.47
, pp. 425-432
-
-
Mcgeer, P.L.1
Schulzer, M.2
McGeer, E.G.3
-
15
-
-
0028605627
-
Non-steroidal anti-inflammatory drug use in Alzheimer's disease
-
Lucca U, Comelli M, Tettamanti M, Tiraboschi P, Spagnoli A. Non-steroidal anti-inflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994; 36(12):854-856.
-
(1994)
Biol Psychiatry
, vol.36
, Issue.12
, pp. 854-856
-
-
Lucca, U.1
Comelli, M.2
Tettamanti, M.3
Tiraboschi, P.4
Spagnoli, A.5
-
16
-
-
0028896679
-
Non-steroidal anti-inflammatory drugs in Alzheimer's disease
-
Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. Non-steroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995; 45(1):51-55.
-
(1995)
Neurology
, vol.45
, Issue.1
, pp. 51-55
-
-
Rich, J.B.1
Rasmusson, D.X.2
Folstein, M.F.3
Carson, K.A.4
Kawas, C.5
Brandt, J.6
-
17
-
-
0027268393
-
Clinical trial of indomethacin in Alzheimer's disease
-
Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993; 43(8):1609-1611.
-
(1993)
Neurology
, vol.43
, Issue.8
, pp. 1609-1611
-
-
Rogers, J.1
Kirby, L.C.2
Hempelman, S.R.3
Berry, D.L.4
McGeer, P.L.5
Kaszniak, A.W.6
Zalinski, J.7
Cofield, M.8
Mansukhani, L.9
Willson, P.10
-
18
-
-
0032551633
-
Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
-
Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998; 87(2):319-324.
-
(1998)
Neuroscience
, vol.87
, Issue.2
, pp. 319-324
-
-
Pasinetti, G.M.1
Aisen, P.S.2
-
20
-
-
0021520020
-
A new rating scale for Alzheimer's disease
-
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psych 1984; 141:1356-1364.
-
(1984)
Am J Psych
, vol.141
, pp. 1356-1364
-
-
Rosen, W.G.1
Mohs, R.C.2
Davis, K.L.3
-
21
-
-
0026327916
-
A new assessment tool for neuropsychopharmacologic research: The Computerized Neuropsychological Test Battery
-
Veroff AE, Cutler NR, Sramek JJ, Prior PL, Mickelson W, Hartmann JK. A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test Battery. J Geriatr Psychiatry Neurol 1991; 4(4):211-217.
-
(1991)
J Geriatr Psychiatry Neurol
, vol.4
, Issue.4
, pp. 211-217
-
-
Veroff, A.E.1
Cutler, N.R.2
Sramek, J.J.3
Prior, P.L.4
Mickelson, W.5
Hartmann, J.K.6
-
22
-
-
0003012239
-
Results of double-blind, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer's disease
-
Stockholm, Apr 5-8
-
Sainati SM, Ingram DM, Talwaker S, et al. Results of double-blind, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer's disease (abstract). 6th International Stockholm-Springfield Symposium of Advances in Alzheimer Therapy, Stockholm, Apr 5-8, 2000.
-
(2000)
6th International Stockholm-Springfield Symposium of Advances in Alzheimer Therapy
-
-
Sainati, S.M.1
Ingram, D.M.2
Talwaker, S.3
-
23
-
-
0031897295
-
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease
-
Cutler NR, Polinsky RJ, Sramek JJ, Enz A, Jhee SS, Mancione L, Hourani J, Zolnouni P. Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta Neurol Scand 1998; 97:244-250.
-
(1998)
Acta Neurol Scand
, vol.97
, pp. 244-250
-
-
Cutler, N.R.1
Polinsky, R.J.2
Sramek, J.J.3
Enz, A.4
Jhee, S.S.5
Mancione, L.6
Hourani, J.7
Zolnouni, P.8
-
24
-
-
0033507971
-
Treatment of osteoarthritis with celcoxib, a cyclooxeganase-2 inhibitor: A randomized controlled trial
-
Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC. Treatment of osteoarthritis with celcoxib, a cyclooxeganase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc 1999; 74(11):105-1095.
-
(1999)
Mayo Clin Proc
, vol.74
, Issue.11
, pp. 105-1095
-
-
Bensen, W.G.1
Fiechtner, J.J.2
McMillen, J.I.3
Zhao, W.W.4
Yu, S.S.5
Woods, E.M.6
Hubbard, R.C.7
Isakson, P.C.8
-
25
-
-
0037006122
-
Vioxx, Acetaminophen
-
Celecoxib Trial (VACT) Group
-
Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ. Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group. JAMA 2002; 287(1):64-71.
-
(2002)
JAMA
, vol.287
, Issue.1
, pp. 64-71
-
-
Geba, G.P.1
Weaver, A.L.2
Polis, A.B.3
Dixon, M.E.4
Schnitzer, T.J.5
-
26
-
-
0035678143
-
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip
-
Kivitz AJ, Moskowits RW, Woods E, Hubbard RC, Verburg KM, Lefkowith JB, Geis GS. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip. J Int Med Res 2001; 29(6):467-479.
-
(2001)
J Int Med Res
, vol.29
, Issue.6
, pp. 467-479
-
-
Kivitz, A.J.1
Moskowits, R.W.2
Woods, E.3
Hubbard, R.C.4
Verburg, K.M.5
Lefkowith, J.B.6
Geis, G.S.7
-
27
-
-
0035080478
-
Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults
-
Gimbel JS, Brugger A, Zhao W, Verburg KM, Geis GS. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther 2001; 23(2):228-241.
-
(2001)
Clin Ther
, vol.23
, Issue.2
, pp. 228-241
-
-
Gimbel, J.S.1
Brugger, A.2
Zhao, W.3
Verburg, K.M.4
Geis, G.S.5
-
28
-
-
0035113787
-
Celcoxib versus diclofenac in the mangement of osteoarthritis of the knee
-
McKenna F, Borenstein D, Wendt H, Wallemark C, Lefkowith JB, Geis GS. Celcoxib versus diclofenac in the mangement of osteoarthritis of the knee. Scand J Rheumatol 2001; 30(1):11-18.
-
(2001)
Scand J Rheumatol
, vol.30
, Issue.1
, pp. 11-18
-
-
McKenna, F.1
Borenstein, D.2
Wendt, H.3
Wallemark, C.4
Lefkowith, J.B.5
Geis, G.S.6
-
29
-
-
0033927533
-
Cyclo-oxygenase-2 inhibitors. Rationale and therapeutic potential for Alzheimer's disease
-
McGeer PL. Cyclo-oxygenase-2 inhibitors. Rationale and therapeutic potential for Alzheimer's disease. Drugs Aging 2000; 17(1):1-11.
-
(2000)
Drugs Aging
, vol.17
, Issue.1
, pp. 1-11
-
-
McGeer, P.L.1
|